Amicus Therapeutics Inc. buy StockNews.com
Start price
11.03.23
/
50%
€10.70
Target price
11.03.24
-
Performance (%)
2.80%
End price
12.03.24
€11.00
Summary
This prediction ended on 12.03.24 with a price of €11.00. The BUY prediction by StockNews_com finished with a performance of 2.80%. StockNews_com has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -3.165% | -3.165% | -23.500% |
| iShares Core DAX® | -0.917% | -3.612% | 22.956% |
| iShares Nasdaq 100 | -3.301% | -0.193% | 10.320% |
| iShares Nikkei 225® | -4.194% | 3.000% | 18.193% |
| iShares S&P 500 | -1.866% | -0.116% | 5.023% |
Comments by StockNews_com for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.20
16.11.24
16.11.24
-
16.11.25
16.11.25
-16.30%
07.11.25
07.11.25
Stopped prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.45
26.10.25
26.10.25
-
26.10.26
26.10.26
2.68%
07.11.25
07.11.25